Cargando…

RASAL2 Deficiency Attenuates Hepatic Steatosis by Promoting Hepatic VLDL Secretion via the AKT/TET1/MTTP Axis

BACKGROUND AND AIMS: RAS protein activator like 2 (RASAL2) is a newly discovered metabolic regulator involved in energy homeostasis and adipogenesis. However, whether RASAL2 is involved in hepatic lipid metabolism remains undetermined. This study explored the function of RASAL2 and elucidated its po...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Hao, Yu, Jiang-Hong, Ge, Ge, Ma, Yan-Yun, Wang, Jiu-Cun, Zhang, Jun, Liu, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	XIA & HE Publishing Inc. 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817063/ https://www.ncbi.nlm.nih.gov/pubmed/36643045 http://dx.doi.org/10.14218/JCTH.2022.00042

Ejemplares similares

Long Noncoding RNA lncRHL Regulates Hepatic VLDL Secretion by Modulating hnRNPU/BMAL1/MTTP Axis
por: Shen, Xuan, et al.
Publicado: (2022)

Association between MTTP genotype (-493G/T) polymorphism and hepatic steatosis in hepatitis C: a systematic review and meta-analysis
por: Wang, Xiaoxia, et al.
Publicado: (2023)

Membrane-bound sn-1,2-diacylglycerols explain the dissociation of hepatic insulin resistance from hepatic steatosis in MTTP knockout mice
por: Abulizi, Abudukadier, et al.
Publicado: (2020)

Effect of MTTP -493G/T, I128T, Q95H and Q244E polymorphisms on hepatic steatosis in patients with chronic hepatitis
por: Prata, Thamiris Vaz Gago, et al.
Publicado: (2022)

Liver-specific deletion of Mttp versus Tm6sf2 reveals distinct defects in stepwise VLDL assembly
por: Newberry, Elizabeth P., et al.
Publicado: (2021)

ChREBP Rather Than SHP Regulates Hepatic VLDL Secretion
por: Niwa, Hiroyuki, et al.
Publicado: (2018)

Loss of hepatic SMLR1 causes hepatosteatosis and protects against atherosclerosis due to decreased hepatic VLDL secretion
por: van Zwol, Willemien, et al.
Publicado: (2023)

Recent progress in understanding protein and lipid factors affecting hepatic VLDL assembly and secretion
por: Sundaram, Meenakshi, et al.
Publicado: (2010)

Bariatric surgery improves postprandial VLDL kinetics and restores insulin-mediated regulation of hepatic VLDL production
por: Yildirim, Vehpi, et al.
Publicado: (2023)

GLP-1 Receptor Activation Inhibits VLDL Production and Reverses Hepatic Steatosis by Decreasing Hepatic Lipogenesis in High-Fat-Fed APOE*3-Leiden Mice
por: Parlevliet, Edwin T., et al.
Publicado: (2012)

RASAL1 is a potent regulator of hepatic stellate cell activity and liver fibrosis
por: Takata, Akemi, et al.
Publicado: (2017)

Atherosclerosis-associated hepatic secretion of VLDL but not PCSK9 is dependent on cargo receptor protein Surf4
por: Wang, Bingxiang, et al.
Publicado: (2021)

Pathophysiological importance of bile cholesterol reabsorption: hepatic NPC1L1-exacerbated steatosis and decreasing VLDL-TG secretion in mice fed a high-fat diet
por: Toyoda, Yu, et al.
Publicado: (2019)

Hemodynamic changes in hepatic sinusoids of hepatic steatosis mice
por: Fan, Jing, et al.
Publicado: (2019)

Hepatic deficiency of selenoprotein S exacerbates hepatic steatosis and insulin resistance
por: Qiao, Lu, et al.
Publicado: (2022)

Empagliflozin Alleviates Hepatic Steatosis by Activating the AMPK-TET2-Autophagy Pathway in vivo and in vitro
por: Li, Ting, et al.
Publicado: (2021)

Hypothalamic Neuropeptide Y (NPY) Controls Hepatic VLDL-Triglyceride Secretion in Rats via the Sympathetic Nervous System
por: Bruinstroop, Eveline, et al.
Publicado: (2012)

Hepatic Expression of the Serine Palmitoyltransferase Subunit Sptlc2 Reduces Lipid Droplets in the Liver by Activating VLDL Secretion
por: Kim, Goon-Tae, et al.
Publicado: (2020)

Activation of microRNA-378a-3p biogenesis promotes hepatic secretion of VLDL and hyperlipidemia by modulating ApoB100-Sortilin1 axis
por: Zhang, Tianpeng, et al.
Publicado: (2020)

Fucoidan and Fucoxanthin Attenuate Hepatic Steatosis and Inflammation of NAFLD through Modulation of Leptin/Adiponectin Axis
por: Shih, Ping-Hsiao, et al.
Publicado: (2021)

Rasal2 deficiency reduces adipogenesis and occurrence of obesity-related disorders
por: Zhu, Xiaoqiang, et al.
Publicado: (2017)

VLDL Hydrolysis by Hepatic Lipase Regulates PPARδ Transcriptional Responses
por: Brown, Jonathan D., et al.
Publicado: (2011)

Reduction of VLDL Secretion Decreases Cholesterol Excretion in Niemann-Pick C1-Like 1 Hepatic Transgenic Mice
por: Marshall, Stephanie M., et al.
Publicado: (2014)

Dysfunction of estrogen-related receptor alpha-dependent hepatic VLDL secretion contributes to sex disparity in NAFLD/NASH development
por: Yang, Meng, et al.
Publicado: (2020)

Long-term Stress with Hyperglucocorticoidemia-induced Hepatic Steatosis with VLDL Overproduction Is Dependent on both 5-HT2 Receptor and 5-HT Synthesis in Liver
por: Fu, Jihua, et al.
Publicado: (2016)

Protective Effect of Patchouli Alcohol Against High-Fat Diet Induced Hepatic Steatosis by Alleviating Endoplasmic Reticulum Stress and Regulating VLDL Metabolism in Rats
por: Wu, Xue, et al.
Publicado: (2019)

Naringenin attenuates hepatitis B virus X protein-induced hepatic steatosis
por: Lin, Hung-Jen, et al.
Publicado: (2017)

Osteopontin deficiency protects against obesity-induced hepatic steatosis and attenuates glucose production in mice
por: Kiefer, F. W., et al.
Publicado: (2011)

CD36/Sirtuin 1 Axis Impairment Contributes to Hepatic Steatosis in ACE2-Deficient Mice
por: Nunes-Souza, Valéria, et al.
Publicado: (2016)

Hepatic SH2B1 and SH2B2 Regulate Liver Lipid Metabolism and VLDL Secretion in Mice
por: Sheng, Liang, et al.
Publicado: (2013)

Hepatic VLDL secretion: DGAT1 determines particle size but not particle number, which can be supported entirely by DGAT2
por: Irshad, Zehra, et al.
Publicado: (2019)

The hepatic AMPK-TET1-SIRT1 axis regulates glucose homeostasis
por: Zhang, Chunbo, et al.
Publicado: (2021)

Butyrate Attenuates Hepatic Steatosis Induced by a High‐Fat and Fiber‐Deficient Diet via the Hepatic GPR41/43‐CaMKII/HDAC1‐CREB Pathway
por: Zheng, Mingxuan, et al.
Publicado: (2022)

IL-33 treatment attenuated diet-induced hepatic steatosis but aggravated hepatic fibrosis
por: Gao, Yinjie, et al.
Publicado: (2016)

Decreases in the Serum VLDL-TG/Non-VLDL-TG Ratio from Early Stages of Chronic Hepatitis C: Alterations in TG-Rich Lipoprotein Levels
por: Nishimura, Motoi, et al.
Publicado: (2011)

Reproducibility of ultrasound attenuation imaging for the noninvasive evaluation of hepatic steatosis
por: Yoo, Jeongin, et al.
Publicado: (2020)

Feasibility of Ultrasound Attenuation Imaging for Assessing Pediatric Hepatic Steatosis
por: Song, Kyungchul, et al.
Publicado: (2022)

Noninvasive assessment of paediatric hepatic steatosis by using attenuation imaging
por: Hwang, Sook Min, et al.
Publicado: (2023)

Angiotensin-converting enzyme 2/angiotensin-(1–7)/Mas axis activates Akt signaling to ameliorate hepatic steatosis
por: Cao, Xi, et al.
Publicado: (2016)

Hepatic MDM2 Causes Metabolic Associated Fatty Liver Disease by Blocking Triglyceride‐VLDL Secretion via ApoB Degradation
por: Lin, Huige, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e8n2tba6usi5jne33r2k819bqc